Boosting NAD+ with a small molecule that activates NAMPT
Nicotinamide phosphoribosyltransferase (NAMPT) catalyzes the rate determining step for NAD+ synthesis and is of interest as a drug target. Here the authors identify and characterize a small molecule NAMPT activator SBI-797812, elucidate its mode of action and show that it increases intracellular NMN...
Saved in:
Main Authors: | Stephen J. Gardell, Meghan Hopf, Asima Khan, Mauro Dispagna, E. Hampton Sessions, Rebecca Falter, Nidhi Kapoor, Jeanne Brooks, Jeffrey Culver, Chris Petucci, Chen-Ting Ma, Steven E. Cohen, Jun Tanaka, Emmanuel S. Burgos, Jennifer S. Hirschi, Steven R. Smith, Eduard Sergienko, Anthony B. Pinkerton |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/1414d8924adf4074afe7c8dc6bbcf1cf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation through parthanatos cell death.
by: Francisco J Martínez-Morcillo, et al.
Published: (2021) -
NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation through parthanatos cell death
by: Francisco J. Martínez-Morcillo, et al.
Published: (2021) -
A decrease in NAMPT activity impairs basal PARP-1 activity in cytidine deaminase deficient-cells, independently of NAD+
by: Sandra Cunha Silveira, et al.
Published: (2020) -
Effect of NAD+ boosting on kidney ischemia-reperfusion injury.
by: Marya Morevati, et al.
Published: (2021) -
Endothelial eNAMPT drives EndMT and preclinical PH: rescue by an eNAMPT-neutralizing mAb
by: Mohamed Ahmed, et al.
Published: (2021)